FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2336795951> ?p ?o ?g. }

• W2336795951 endingPage "652" @default.
• W2336795951 startingPage "639" @default.
• W2336795951 abstract "Introduction: By activating DP1 and DP2 receptors on immune and non-immune cells, prostaglandin D2 (PGD2), a major metabolic product of cyclo-oxygenase pathway released after IgE-mediated mast cell activation, has pro-inflammatory effects, which are relevant to the pathophysiology of allergic airway disease. At least 15 selective, orally active, DP2 receptor antagonists and one DP1 receptor antagonist (asapiprant) are under development for asthma and/or allergic rhinitis.Areas covered: In this review, the authors cover the pharmacology of PGD2 and PGD2 receptor antagonists and look at the preclinical, phase I and phase II studies with selective DP1 and DP2 receptor antagonists.Expert opinion: Future research should aim to develop once daily compounds and increase the drug clinical potency which, apart from OC000459 and ADC-3680, seems to be relatively low.Further research and development of DP2 receptor antagonists is warranted, particularly in patients with severe uncontrolled asthma, whose management is a top priority. Pediatric studies, which are not available, are required for assessing the efficacy and safety of this novel drug class in children with asthma and allergic rhinitis. Studies on the efficacy of DP2 receptor antagonists in various asthma phenotypes including: smokers, obese subjects, early vs late asthma onset, fixed vs reversible airflow limitation, are required for establishing their pharmacotherapeutic role." @default.
• W2336795951 created "2016-06-24" @default.
• W2336795951 creator A5008742147 @default.
• W2336795951 creator A5011441252 @default.
• W2336795951 creator A5021762566 @default.
• W2336795951 creator A5026176890 @default.
• W2336795951 creator A5056375198 @default.
• W2336795951 creator A5078245292 @default.
• W2336795951 date "2016-04-25" @default.
• W2336795951 modified "2023-10-18" @default.
• W2336795951 title "Investigational prostaglandin D₂receptor antagonists for airway inflammation" @default.
• W2336795951 cites W1187428823 @default.
• W2336795951 cites W1512168554 @default.
• W2336795951 cites W1516009098 @default.
• W2336795951 cites W1535429252 @default.
• W2336795951 cites W1901282726 @default.
• W2336795951 cites W1911339339 @default.
• W2336795951 cites W1943874467 @default.
• W2336795951 cites W1967105697 @default.
• W2336795951 cites W1969627458 @default.
• W2336795951 cites W1972502379 @default.
• W2336795951 cites W1977368405 @default.
• W2336795951 cites W1982158616 @default.
• W2336795951 cites W1982358898 @default.
• W2336795951 cites W1982886076 @default.
• W2336795951 cites W1985242752 @default.
• W2336795951 cites W1986935281 @default.
• W2336795951 cites W1990094979 @default.
• W2336795951 cites W1992834564 @default.
• W2336795951 cites W2000235754 @default.
• W2336795951 cites W2001557781 @default.
• W2336795951 cites W2001677668 @default.
• W2336795951 cites W2007164485 @default.
• W2336795951 cites W2008623593 @default.
• W2336795951 cites W2013167752 @default.
• W2336795951 cites W2018464738 @default.
• W2336795951 cites W2022426219 @default.
• W2336795951 cites W2022585439 @default.
• W2336795951 cites W2023631199 @default.
• W2336795951 cites W2025228731 @default.
• W2336795951 cites W2027223183 @default.
• W2336795951 cites W2031498189 @default.
• W2336795951 cites W2033050749 @default.
• W2336795951 cites W2036990299 @default.
• W2336795951 cites W2043456386 @default.
• W2336795951 cites W2048244406 @default.
• W2336795951 cites W2051693683 @default.
• W2336795951 cites W2051913840 @default.
• W2336795951 cites W2052342760 @default.
• W2336795951 cites W2063924884 @default.
• W2336795951 cites W2067223664 @default.
• W2336795951 cites W2068797169 @default.
• W2336795951 cites W2070235550 @default.
• W2336795951 cites W2072213636 @default.
• W2336795951 cites W2073939652 @default.
• W2336795951 cites W2078915983 @default.
• W2336795951 cites W2080199955 @default.
• W2336795951 cites W2081067445 @default.
• W2336795951 cites W2084615605 @default.
• W2336795951 cites W2085261826 @default.
• W2336795951 cites W2087184841 @default.
• W2336795951 cites W2098967308 @default.
• W2336795951 cites W2100872205 @default.
• W2336795951 cites W2101386620 @default.
• W2336795951 cites W2121533007 @default.
• W2336795951 cites W2122556001 @default.
• W2336795951 cites W2122749412 @default.
• W2336795951 cites W2124251887 @default.
• W2336795951 cites W2130212172 @default.
• W2336795951 cites W2130579948 @default.
• W2336795951 cites W2130761360 @default.
• W2336795951 cites W2138002178 @default.
• W2336795951 cites W2140688081 @default.
• W2336795951 cites W2142249600 @default.
• W2336795951 cites W2157931212 @default.
• W2336795951 cites W2162617604 @default.
• W2336795951 cites W2166893697 @default.
• W2336795951 cites W2169506749 @default.
• W2336795951 cites W2297115086 @default.
• W2336795951 cites W2313856416 @default.
• W2336795951 cites W2317155281 @default.
• W2336795951 cites W2325867107 @default.
• W2336795951 cites W2402136807 @default.
• W2336795951 cites W2552356967 @default.
• W2336795951 cites W4378211727 @default.
• W2336795951 doi "https://doi.org/10.1080/13543784.2016.1175434" @default.
• W2336795951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27094922" @default.
• W2336795951 hasPublicationYear "2016" @default.
• W2336795951 type Work @default.
• W2336795951 sameAs 2336795951 @default.
• W2336795951 citedByCount "20" @default.
• W2336795951 countsByYear W23367959512016 @default.
• W2336795951 countsByYear W23367959512017 @default.
• W2336795951 countsByYear W23367959512018 @default.
• W2336795951 countsByYear W23367959512019 @default.
• W2336795951 countsByYear W23367959512020 @default.
• W2336795951 countsByYear W23367959512021 @default.
• W2336795951 countsByYear W23367959512022 @default.

• next